PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Zanjan University of Medical Sciences, Zanjan, Iran.\', \'School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran.\', \'Department of Immunology, Zanjan University of Medical Sciences, Zanjan, Iran; Cancer Gene Therapy Research Center (CGRC), Zanjan University of Medical Sciences, Zanjan, Iran. Electronic address: a46reza@zums.ac.ir.\']
?:citedBy
  • -1
?:creator
?:doi
  • S1567-5769(22)00020-010.1016/j.intimp.2022.108536
?:doi
?:hasPublicationType
?:journal
  • International immunopharmacology
is ?:pmid of
?:pmid
?:pmid
  • 35074571
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.051
?:rankingScore_hIndex
  • 94
?:title
  • An updated overview of recent advances, challenges, and clinical considerations of IL-6 signaling blockade in severe coronavirus disease 2019 (COVID-19).
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all